Last 7 days
3%
Last 30 days
-9.2%
Last 90 days
-7.8%
Trailing 12 Months
-33.7%
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
SYK | 104.1B | 18.4B | 2.26% | 8.00% | 44.16 | 5.64 | 7.84% | 18.25% |
ISRG | 84.2B | 6.2B | -4.47% | -13.27% | 63.66 | 13.53 | 8.97% | -22.43% |
BSX | 69.1B | 12.7B | 0.59% | 12.45% | 99.06 | 5.45 | 6.68% | -32.95% |
BDX | 67.4B | 19.0B | -5.16% | -6.78% | 41.86 | 3.55 | -0.43% | -8.78% |
EW | 49.8B | 5.4B | 2.41% | -25.12% | 32.74 | 9.26 | 2.86% | 1.25% |
MID-CAP | ||||||||
SWAV | 7.2T | 489.7M | 9.34% | 31.15% | 82.2K | 16.8K | 106.51% | 2464.23% |
PEN | 10.2B | 847.1M | -3.64% | 34.52% | -5.1K | 12.05 | 13.32% | -137.89% |
GMED | 5.2B | 1.0B | -11.64% | -20.31% | 30.19 | 5.09 | 6.76% | 24.45% |
IRTC | 3.5B | 410.9M | 4.51% | -3.13% | -29.82 | 8.43 | 27.29% | -14.60% |
TNDM | 2.7B | 801.2M | 1.13% | -58.87% | -28.25 | 3.34 | 14.00% | -707.69% |
SMALL-CAP | ||||||||
SILK | 1.7B | 138.6M | -15.68% | 29.18% | -30.43 | 12.07 | 36.62% | -10.44% |
ATEC | 1.6B | 350.9M | 10.38% | 49.06% | -10.84 | 4.7 | 44.26% | -5.42% |
AVNS | 1.3B | 820.0M | -8.35% | -12.22% | 25.89 | 1.59 | 10.13% | 701.59% |
CSII | 828.4M | 239.8M | 0.30% | 1.49% | -21.88 | 3.45 | -4.74% | -31.15% |
Income Statement (Last 12 Months) | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Revenue | 4.7% | 330 | 316 | 303 | 290 | 274 |
Cost Of Revenue | 5.9% | 84.00 | 80.00 | 76.00 | 73.00 | 68.00 |
Gross Profit | 4.3% | 246 | 236 | 226 | 217 | 206 |
Operating Expenses | 0.6% | 289 | 287 | 168 | 160 | 151 |
S&GA Expenses | 0.8% | 231 | 229 | 222 | 217 | 205 |
R&D Expenses | -0.1% | 57.00 | 57.00 | 54.00 | 51.00 | 49.00 |
EBITDA | 23.9% | -33.15 | -43.59 | 66.00 | 64.00 | - |
EBITDA Margin | 27.3% | -0.10* | -0.14* | 0.22* | 0.22* | - |
Earnings Before Taxes | 17.3% | -46.20 | -55.84 | 54.00 | 52.00 | 50.00 |
EBT Margin | 21.0% | -0.14* | -0.18* | 0.18* | 0.18* | - |
Interest Expenses | 10.6% | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 |
Net Income | 17.1% | -46.47 | -56.04 | 53.00 | 52.00 | 50.00 |
Net Income Margin | 20.8% | -0.14* | -0.18* | 0.18* | 0.18* | - |
Free Cahsflow | -4.6% | -39.02 | -37.31 | -32.11 | -40.90 | - |
Balance Sheet | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Assets | 0.6% | 585 | 582 | 587 | 585 | 615 |
Current Assets | 1.4% | 215 | 212 | 206 | 200 | 196 |
Cash Equivalents | 19.0% | 58.00 | 49.00 | 55.00 | 28.00 | 44.00 |
Inventory | 4.5% | 46.00 | 44.00 | 41.00 | 41.00 | 39.00 |
Net PPE | 6.9% | 39.00 | 36.00 | 33.00 | 31.00 | - |
Goodwill | 0% | 235 | 235 | 235 | 235 | 235 |
Liabilities | -2.2% | 129 | 132 | 131 | 122 | 132 |
Current Liabilities | 1.4% | 58.00 | 58.00 | 56.00 | 47.00 | 56.00 |
LT Debt, Non Current | -5.4% | 57.00 | 60.00 | 60.00 | 60.00 | 60.00 |
Shareholder's Equity | 1.4% | 457 | 450 | 457 | 463 | 484 |
Retained Earnings | -1.3% | -326 | -322 | -310 | -295 | -280 |
Additional Paid-In Capital | 1.2% | 787 | 778 | 771 | 762 | 765 |
Shares Outstanding | 0.3% | 47.00 | 46.00 | 46.00 | 46.00 | 46.00 |
Cashflow (Last 12 Months) | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Cashflow From Operations | -1.2% | -22.14 | -21.89 | -20.33 | -29.10 | -13.78 |
Share Based Compensation | -1.2% | 29.00 | 29.00 | 29.00 | 29.00 | 28.00 |
Cashflow From Investing | 15.6% | 44.00 | 38.00 | 16.00 | -20.36 | 24.00 |
Cashflow From Financing | -8.0% | -7.06 | -6.53 | -8.39 | -7.43 | -7.64 |
90%
56.1%
36.1%
Y-axis is the maximum loss one would have experienced if AtriCure was unfortunately bought at previous high price.
16.3%
12.3%
13.2%
8.8%
FIve years rolling returns for AtriCure.
Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
2023-03-10 | VICTORY CAPITAL MANAGEMENT INC | added | 91.15 | 299,217 | 554,217 | -% |
2023-03-06 | Rockefeller Capital Management L.P. | added | 15.01 | 25,000 | 108,000 | -% |
2023-02-28 | Voya Investment Management LLC | reduced | -79.31 | -2,525,950 | 775,052 | -% |
2023-02-24 | SRS Capital Advisors, Inc. | unchanged | - | 21.00 | 1,021 | -% |
2023-02-21 | MACQUARIE GROUP LTD | added | 1.00 | 7,768,000 | 61,065,000 | 0.07% |
2023-02-17 | TRUIST FINANCIAL CORP | reduced | -22.51 | -126,372 | 914,628 | -% |
2023-02-16 | CHARTWELL INVESTMENT PARTNERS, LLC | added | 6.05 | 154,000 | 913,000 | 0.04% |
2023-02-15 | JANE STREET GROUP, LLC | added | 13.11 | 140,741 | 637,741 | -% |
2023-02-15 | MBM Wealth Consultants, LLC | new | - | 3,000 | 3,000 | -% |
2023-02-15 | Steward Partners Investment Advisory, LLC | sold off | -100 | -1,000 | - | -% |
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Feb 14, 2023 | alliancebernstein l.p. | 7.7% | 3,565,726 | SC 13G/A | |
Feb 14, 2023 | alger associates inc | 3.8% | 1,755,398 | SC 13G/A | |
Feb 09, 2023 | vanguard group inc | 9.44% | 4,389,815 | SC 13G/A | |
Feb 03, 2023 | blackrock inc. | 8.0% | 3,735,766 | SC 13G/A | |
Feb 03, 2023 | invesco ltd. | 7.2% | 3,367,324 | SC 13G/A | |
Feb 14, 2022 | price t rowe associates inc /md/ | 4.2% | 1,945,751 | SC 13G/A | |
Feb 14, 2022 | alliancebernstein l.p. | 7.5% | 3,455,856 | SC 13G | |
Feb 14, 2022 | alger associates inc | 7.1% | 3,240,847 | SC 13G/A | |
Feb 09, 2022 | vanguard group inc | 9.22% | 4,234,298 | SC 13G/A | |
Feb 09, 2022 | invesco ltd. | 5.3% | 2,437,617 | SC 13G/A |
Fair Value | Very Pessimistic | Pessimistic | Base Case | Optimistic | Very Optimistic |
---|---|---|---|---|---|
Very Low Inflation | 6.08 -84.55% | 7.25 -81.58% | 9.10 -76.87% | 10.74 -72.71% | 12.13 -69.17% |
Current Inflation | 5.77 -85.34% | 6.78 -82.77% | 8.34 -78.81% | 9.71 -75.32% | 10.87 -72.38% |
Very High Inflation | 5.39 -86.30% | 6.21 -84.22% | 7.43 -81.12% | 8.51 -78.37% | 9.42 -76.06% |
Date Filed | Form Type | Document | |
---|---|---|---|
Mar 15, 2023 | 4 | Insider Trading | |
Mar 03, 2023 | 4 | Insider Trading | |
Mar 03, 2023 | 4 | Insider Trading | |
Mar 03, 2023 | 4 | Insider Trading | |
Mar 03, 2023 | 4 | Insider Trading | |
Mar 03, 2023 | 4 | Insider Trading | |
Mar 03, 2023 | 4 | Insider Trading | |
Mar 03, 2023 | 4 | Insider Trading | |
Mar 03, 2023 | 4 | Insider Trading | |
Mar 01, 2023 | 4 | Insider Trading |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
2023-03-13 | Collar Mark A | acquired | 93,000 | 9.3 | 10,000 | - |
2023-03-01 | Privitera Salvatore | acquired | - | - | 24,140 | chief technical officer |
2023-03-01 | Yount Deborah Lee | acquired | - | - | 12,239 | chief human resources officer |
2023-03-01 | Wirick Angela L | sold (taxes) | -137,077 | 38.81 | -3,532 | chief financial officer |
2023-03-01 | Noznesky Justin J | sold (taxes) | -274,891 | 38.81 | -7,083 | chief mktg & strategy officer |
2023-03-01 | Seith Douglas J | acquired | - | - | 42,507 | chief operating officer |
2023-03-01 | Wirick Angela L | acquired | - | - | 24,478 | chief financial officer |
2023-03-01 | Seith Douglas J | sold (taxes) | -453,572 | 38.81 | -11,687 | chief operating officer |
2023-03-01 | Doraiswamy Vinayak | acquired | - | - | 24,140 | chief scientific officer |
2023-03-01 | Dahlquist Karl S. | sold (taxes) | -267,556 | 38.81 | -6,894 | chief legal officer |
Consolidated Statements of Operations and Comprehensive Income (Loss) - USD ($) shares in Thousands, $ in Thousands | 12 Months Ended | ||
---|---|---|---|
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Income Statement [Abstract] | |||
Revenue | $ 330,379 | $ 274,329 | $ 206,531 |
Cost of revenue | 84,439 | 68,469 | 57,222 |
Gross profit | 245,940 | 205,860 | 149,309 |
Operating expenses (benefit): | |||
Research and development expenses | 57,337 | 48,506 | 43,070 |
Selling, general and administrative expenses | 231,272 | 204,649 | 150,829 |
Change in fair value of contingent consideration (Note 2) | 0 | (184,800) | (357) |
Intangible asset impairment (Note 4) | 0 | 82,300 | 0 |
Total operating expenses | 288,609 | 150,655 | 193,542 |
(Loss) income from operations | (42,669) | 55,205 | (44,233) |
Other income (expense): | |||
Interest expense | (4,986) | (4,918) | (4,885) |
Interest income | 1,994 | 466 | 1,101 |
Other | (537) | (366) | (24) |
(Loss) income before income tax expense | (46,198) | 50,387 | (48,041) |
Income tax expense | 268 | 188 | 114 |
Net (loss) income | $ (46,466) | $ 50,199 | $ (48,155) |
Basic net (loss) income per share (in usd per share) | $ (1.02) | $ 1.11 | $ (1.14) |
Diluted net (loss) income per share (in usd per share) | $ (1.02) | $ 1.09 | $ (1.14) |
Weighted average shares outstanding, basic (in shares) | 45,740 | 45,066 | 42,125 |
Weighted average shares outstanding, diluted (in shares) | 45,740 | 46,039 | 42,125 |
Comprehensive (loss) income: | |||
Unrealized loss on investments | $ (2,811) | $ (941) | $ (46) |
Foreign currency translation adjustment | (337) | (319) | 516 |
Other comprehensive (loss) income | (3,148) | (1,260) | 470 |
Net (loss) income | (46,466) | 50,199 | (48,155) |
Comprehensive (loss) income, net of tax | $ (49,614) | $ 48,939 | $ (47,685) |
Consolidated Balance Sheets - USD ($) | Dec. 31, 2022 | Dec. 31, 2021 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 58,099,000 | $ 43,654,000 |
Short-term investments | 63,014,000 | 75,436,000 |
Accounts receivable, less allowance for credit losses of $230 and $1,096 | 42,693,000 | 33,021,000 |
Inventories | 45,931,000 | 38,964,000 |
Prepaid and other current assets | 5,477,000 | 5,001,000 |
Total current assets | 215,214,000 | 196,076,000 |
Assets, Noncurrent | ||
Long-term investments | 51,509,000 | 104,338,000 |
Property and equipment, net | 38,833,000 | 31,409,000 |
Operating lease right-of-use assets | 3,787,000 | 4,761,000 |
Intangible assets, net | 39,339,000 | 42,992,000 |
Goodwill | 234,781,000 | 234,781,000 |
Other noncurrent assets | 1,985,000 | 955,000 |
Total Assets | 585,448,000 | 615,312,000 |
Current liabilities: | ||
Accounts payable | 19,898,000 | 18,597,000 |
Accrued liabilities | 33,022,000 | 36,092,000 |
Other current liabilities and current maturities of debt and leases | 5,472,000 | 1,756,000 |
Total current liabilities | 58,392,000 | 56,445,000 |
Long-term debt | 56,834,000 | 59,741,000 |
Finance lease liabilities | 9,147,000 | 10,082,000 |
Operating lease liabilities | 3,095,000 | 4,068,000 |
Other noncurrent liabilities | 1,226,000 | 1,220,000 |
Total Liabilities | 128,694,000 | 131,556,000 |
Commitments and contingencies (Note 10) | ||
Stockholders’ Equity: | ||
Common stock, $0.001 par value, 90,000 shares authorized; 46,563 and 46,016 issued and outstanding | 47,000 | 46,000 |
Additional paid-in capital | 787,422,000 | 764,811,000 |
Accumulated other comprehensive loss | (4,096,000) | (948,000) |
Accumulated deficit | (326,619,000) | (280,153,000) |
Total Stockholders’ Equity | 456,754,000 | 483,756,000 |
Total Liabilities and Stockholders’ Equity | $ 585,448,000 | $ 615,312,000 |